Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 2,501–2,550 of 3,109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06703632	Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection(MS-Prevecol)	recruiting	N/A	4,538	ADVANCED MARKER DISCOVERY S.L.INDUSTRY	2	Feb 27, 2025	clinicaltrials
NCT06848582	Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study	recruiting	N/A	40	Sun Yat-sen UniversityOTHER	1	Feb 27, 2025